Skip to main content

Advertisement

SpringerLink
Log in

Giant cell arteritis

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Giant cell, or temporal, arteritis is a vasculitis of the medium and large arteries that preferentially involves vessels originating from the arch of the aorta. Classically, this disease manifests in an older individual with new-onset persistent headache, an abnormal temporal artery on examination, and increased serum inflammatory markers. The level of clinical suspicion for giant cell arteritis should be based upon patient age, clinical symptoms, and laboratory evaluation. However, the diagnostic gold standard is achieved by histologic confirmation by temporal artery biopsy. Prompt treatment with corticosteroids is essential in order to minimize the frequency of permanent sequelae such as visual loss and stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Huston KA, Hunder GG, Lie JT: Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978, 88:162–167.

    PubMed  CAS  Google Scholar 

  2. Lawrence RC, Helmick CG, Arnett FC, et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778–779.

    Article  PubMed  CAS  Google Scholar 

  3. Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG: The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995, 123:192–194.

    PubMed  CAS  Google Scholar 

  4. Salvarani C, Crowson CS, O’Fallon WM, et al.: Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004, 51:264–268. Examined the incidence of GCA and survival among patients with GCA between 1950 and 1999 in Olmsted County, MN.

    Article  PubMed  Google Scholar 

  5. Ostberg G: On arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand 1973, 237(Suppl A):1–59.

    Google Scholar 

  6. Liang GC, Simkin PA, Hunder CC, et al.: Familial aggregation of polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1974, 17:19–24.

    Article  PubMed  CAS  Google Scholar 

  7. Solomon S, Cappa KG: The headache of temporal arteritis. J Am Geriatr Soc 1987, 35:163–165.

    PubMed  CAS  Google Scholar 

  8. Ward TN, Levin M: Headache in giant cell arteritis and other arteritides. Neurol Sci 2005, 26:S134-S137.

    Article  PubMed  Google Scholar 

  9. Headache Classification Committee of the International Headache Society: International Classification of Headache Disorders II. Cephalalgia 2004, 24(Suppl):1-151.

  10. Caselli RJ, Hunder GG: Neurologic aspects of giant cell (temporal) arteritis. Rheum Dis Clin North Am 1993, 19:941–953.

    PubMed  CAS  Google Scholar 

  11. Caselli RJ, Hunder GG, Whisnant JP: Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988, 38:352–359.

    PubMed  CAS  Google Scholar 

  12. Koorey DJ: Cranial arteritis: a twenty-year review of cases. Aust N Z J Med 1984, 14:143–147.

    PubMed  CAS  Google Scholar 

  13. Caselli RJ, Hunder GG: Giant cell (temporal) arteritis. Neurol Clin 1997, 15:893–902.

    Article  PubMed  CAS  Google Scholar 

  14. Cullen JF, Coleiro JA: Ophthalmic complications of giant cell arteritis. Surv Ophthalmol 1976, 20:247–260.

    Article  PubMed  CAS  Google Scholar 

  15. Wagener HP, Hollenhorst RW: The ocular lesions of temporal arteritis. Am J Ophthalmol 1958, 45:617–630.

    PubMed  CAS  Google Scholar 

  16. Lockskin M: Diplopia as early sign of temporal arteritis--report of two cases. Arthritis Rheum 1970, 13:419–421.

    Article  Google Scholar 

  17. Martin EA: Double vision and temporal arteritis. J Ir Med Assoc 1970, 63:191–193.

    PubMed  CAS  Google Scholar 

  18. Killer HE, Holtz DJ, Kaiser HJ, Laeng RH: Diplopia, ptosis, and hepatitis as presenting signs and symptoms of giant cell arteritis. Br J Ophthalmol 2000, 84:1319–1320.

    Article  PubMed  CAS  Google Scholar 

  19. Hayreh SS, Podhajsky PA, Zimmerman B: Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998, 125:521–526.

    Article  PubMed  CAS  Google Scholar 

  20. Hart CJ: Formed visual hallucinations--a symptom of cranial arteritis. Br Med J 1967, 3:643–644.

    PubMed  CAS  Google Scholar 

  21. Liozon E, Ly K, Loustaud V, Vidal E: Visual hallucinations and the risk of visual loss in patients with giant cell (temporal) arteritis. J Rheumatol 2002, 29:855–857.

    PubMed  Google Scholar 

  22. Nesher G, Nesher R, Rozenman Y, Sonnenblick M: Visual hallucinations in giant cell arteritis: association with visual loss. J Rheumatol 2001, 28:2046–2048.

    PubMed  CAS  Google Scholar 

  23. Radda TM, Bardach H, Riss B: Acute ocular hypotony. A rare complication of temporal arteritis. Ophthalmologica 1981, 182:148–152.

    Article  PubMed  CAS  Google Scholar 

  24. Nuenninghoff DM, Hunder GG, Christianson TJH: Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis. Arthritis Rheum 2003, 48:3522–3531.

    Article  PubMed  Google Scholar 

  25. Evans JM, O’Fallon WM, Hunder GG: Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med 1995, 122:502–507.

    PubMed  CAS  Google Scholar 

  26. Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, et al.: Aortic aneurysm and dissection in patients with biopsyproven giant cell arteritis from northwestern Spain. Medicine 2004, 83:335–341.

    Article  PubMed  Google Scholar 

  27. Evans JM, Bowles CA, Bjornsson J, et al.: Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 1994, 37:1539–1547.

    Article  PubMed  CAS  Google Scholar 

  28. Cantini F, Niccoli L, Storri L, et al.: Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 2004, 33:294–301.

    Article  PubMed  Google Scholar 

  29. Gonzalez-Gay MA: Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 2004, 33:289–293. Retrospective review of the literature examining the differences and similarities between GCA and PMR.

    Article  PubMed  Google Scholar 

  30. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT: Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982, 97:672–680.

    PubMed  CAS  Google Scholar 

  31. Wilkinson IM, Russell RW: Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 1972, 27:378–391.

    PubMed  CAS  Google Scholar 

  32. Weyand CM, Goronzy JJ: Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003, 139:505–515.

    PubMed  Google Scholar 

  33. Weyand CM, Goronzy JJ: Medium- and large-vessel vasculitis. N Engl J Med 2003, 349:160–169.

    Article  PubMed  CAS  Google Scholar 

  34. Wagner AD, Gerard HC, Fresemann T, et al.: Detection of Chlamydiae pneumoniae in giant cell vasculitis and correlation with topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum 2000, 43:1543–1551.

    Article  PubMed  CAS  Google Scholar 

  35. Duhaut P, Bosshard S, Dumontet C: Giant cell arteritis and polymyalgia rheumatica: role of viral infections. Clin Exp Rheumatol 2000, 18:S22-S23.

    PubMed  CAS  Google Scholar 

  36. Nordborg C, Nordborg E, Petursdottir V, et al.: Search for varicella zoster virus in giant cell arteritis. Ann Neurol 1998, 44:413–414.

    Article  PubMed  CAS  Google Scholar 

  37. Helweg-Larsen J, Tarp B, Obel N, Baslund B: No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology 2002, 41:445–449.

    Article  PubMed  CAS  Google Scholar 

  38. Roche NE, Fulbright JW, Wagner AD, et al.: Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993, 36:1286–1294.

    Article  PubMed  CAS  Google Scholar 

  39. Andersson R, Malmvall BE, Bengtsson BA: Acute phase reactants in the initial phase of giant cell arteritis. Acta Med Scand 1986, 220:365–367.

    Article  PubMed  CAS  Google Scholar 

  40. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ: The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding side of the HLA-DR molecule. J Clin Invest 1992, 90:2355–2361.

    PubMed  CAS  Google Scholar 

  41. Weyand CM, Hunder NN, Hicok KC, et al.: HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994, 37:514–520.

    Article  PubMed  CAS  Google Scholar 

  42. Niederkohr RD, Levin LA: Management of the patient with suspected temporal arteritis: a decision-analytic approach. Ophthalmology 2005, 112:744–756. A computer-based decision analytic model regarding the interpretation of diagnostic testing and choice of therapy in patients with suspected GCA.

    Article  PubMed  Google Scholar 

  43. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B: Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997, 123:285–296.

    PubMed  CAS  Google Scholar 

  44. Gonzalez-Gay MA, Barcia-Porrua C, Llorca J, et al.: Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001, 30:249–256.

    Article  PubMed  CAS  Google Scholar 

  45. Skaug TR, Midelfart A, Jacobsen G: Clinical usefulness of biopsy in giant cell arteritis. Acta Ophthalmol Scand 1995, 73:567–570.

    Article  PubMed  CAS  Google Scholar 

  46. Chmelewski WL, McKnight KM, Agudelo CA, Wise CM: Presenting features and outcomes in patients undergoing temporal artery biopsy: a review of 98 patients. Arch Intern Med 1992, 152:1690–1695.

    Article  PubMed  CAS  Google Scholar 

  47. Vilaseca J, Gonzalez A, Cid MC, et al.: Clinical usefulness of temporal artery biopsy. Ann Rheum Dis 1987, 46:282–285.

    Article  PubMed  CAS  Google Scholar 

  48. Wong RL, Korn JH: Temporal arteritis without an elevated erythrocyte sedimentation rate: case report and review of the literature. Am J Med 1986, 80:959–964.

    Article  PubMed  CAS  Google Scholar 

  49. Salvarini C, Hunder GG: Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Care Res 2001, 34:217–223.

    Google Scholar 

  50. Foroozan R, Danesh-Meyer H, Savino JP, et al.: Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology 2002, 109:1267–1271.

    Article  PubMed  Google Scholar 

  51. Hunder GG, Bloch DA, Michel BA, et al.: The American College of Rheumatology 1990 criteria for the Classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122–1128.

    Article  PubMed  CAS  Google Scholar 

  52. Sudlow C: Diagnosing and managing polymyalgia rheumatica and temporal arteritis: sensitivity of temporal artery biopsy varies with biopsy length and sectioning strategy. BMJ 1997, 315:549.

    PubMed  CAS  Google Scholar 

  53. Achkar AA, Lie JT, Hunder GG, et al.: How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis. Ann Intern Med 1994, 120:987–992.

    PubMed  CAS  Google Scholar 

  54. Ray-Chaudhuri N, Kine DA, Tijani SO, et al.: Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol 2002, 86:530–532.

    Article  PubMed  CAS  Google Scholar 

  55. Andersson R, Malmvall BE, Bengtsson BA: Long-term corticosteroid treatment in giant cell arteritis. Acta Med Scand 1986, 220:465–469.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8111, 63110, St. Louis, MO, USA

    Todd J. Schwedt MD, David W. Dodick MD & Richard J. Caselli MD

Authors
  1. Todd J. Schwedt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David W. Dodick MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard J. Caselli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Todd J. Schwedt MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwedt, T.J., Dodick, D.W. & Caselli, R.J. Giant cell arteritis. Current Science Inc 10, 415–420 (2006). https://doi.org/10.1007/s11916-006-0071-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-006-0071-6

Keywords

Search

Navigation